Greenblatt HM, Guillou C, Guenard D, Argaman A, Botti SA, Badet B, Thal C, Silman I, Sussman JL (2004)
The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design
Journal of the American Chemical Society 126: 15405

Herlem D, Martin MT, Thal C, Guillou C (2003)
Synthesis and structure-activity relationships of open D-Ring galanthamine analogues
Bioorganic & Medicinal Chemistry Lett 13: 2389

Lamirault L, Guillou C, Thal C, Simon H (2003)
(-)-9-Dehydrogalanthaminium bromide, a new cholinesterase inhibitor, enhances place and object recognition memory in young and old rats
Neurobiol Learn Mem 80: 113

Lamirault L, Guillou C, Thal C, Simon H (2003)
Combined treatment with galanthaminium bromide, a new cholinesterase inhibitor, and RS 67333, a partial agonist of 5-HT4 receptors, enhances place and object recognition in young adult and old rats
Prog Neuropsychopharmacol Biological Psychiatry 27: 185

Guillou C, Mary A, Renko DZ, Gras E, Thal C (2000)
Potent acetylcholinesterase inhibitors: design, synthesis and structure-activity relationships of alkylene linked bis-galanthamine and galanthamine-galanthaminium salts
Bioorganic & Medicinal Chemistry Lett 10: 637

Mary A, Renko DZ, Guillou C, Thal C (1998)
Potent acetylcholinesterase inhibitors: design, synthesis, and structure-activity relationships of bis-interacting ligands in the galanthamine series
Bioorganic & Medicinal Chemistry 6: 1835